Interestingly, although almost all breast, ovarian and pancreatic cancers with BRCA1/2 mutations have large numbers of signature 3 mutations, a number of cancer cases lacking mutations in BRCA1 and BRCA2 or other genes known to play a role in double-strand break repair also exhibit the mutational signature12. This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.